1. Home
  2. VST vs EW Comparison

VST vs EW Comparison

Compare VST & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vistra Corp.

VST

Vistra Corp.

HOLD

Current Price

$147.64

Market Cap

52.1B

Sector

Utilities

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$79.47

Market Cap

50.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VST
EW
Founded
1882
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.1B
50.2B
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
VST
EW
Price
$147.64
$79.47
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$234.09
$96.37
AVG Volume (30 Days)
3.7M
5.2M
Earning Date
05-07-2026
04-23-2026
Dividend Yield
0.59%
N/A
EPS Growth
N/A
N/A
EPS
2.87
0.66
Revenue
$17,738,000,000.00
$6,067,600,000.00
Revenue This Year
$30.97
$13.39
Revenue Next Year
$9.19
$9.81
P/E Ratio
$71.23
$125.47
Revenue Growth
2.98
11.55
52 Week Low
$138.53
$72.30
52 Week High
$219.82
$87.89

Technical Indicators

Market Signals
Indicator
VST
EW
Relative Strength Index (RSI) 39.46 42.71
Support Level $143.72 $76.92
Resistance Level $169.32 $83.19
Average True Range (ATR) 6.79 2.41
MACD -0.90 -0.04
Stochastic Oscillator 1.55 4.43

Price Performance

Historical Comparison
VST
EW

About VST Vistra Corp.

Vistra Corp. is one of the largest power producers and retail energy providers in the USA. It owns 44 gigawatts of generation capacity, including natural gas (27 GW), nuclear (6.5 GW), coal (8.7 GW), and solar and battery storage (1.4 GW). The Cogentrix acquisition will add 5.5 GW of gas generation. Vistra's retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: